Andrea Mcneill

Porirua, WGN, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Large Reductions in Invasive Pneumococcal Disease and Related Morbidities Among Children in New Zealand After Change From PCV10 to PCV13.

Large Reductions in Invasive Pneumococcal Disease and Related Morbidities Among Children in New Zealand After Change From PCV10 to PCV13.

Journal: The Journal of infectious diseases

Published: June 15, 2025

Large Reductions in Invasive Pneumococcal Disease and Related Morbidities Among Children in New Zealand After Change from PCV10 to PCV13.

Large Reductions in Invasive Pneumococcal Disease and Related Morbidities Among Children in New Zealand After Change from PCV10 to PCV13.

Journal: The Journal of infectious diseases

Published: June 15, 2025

Impact of the COVID-19 related border restrictions on influenza and other common respiratory viral infections in New Zealand.

Impact of the COVID-19 related border restrictions on influenza and other common respiratory viral infections in New Zealand.

Journal: Influenza and other respiratory viruses

Published: October 29, 2023

Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border.

Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border.

Journal: Nature communications

Published: July 19, 2022

Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand.

Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand.

Journal: Nature communications

Published: April 04, 2022

Reply to Izurieta et al.

Reply to Izurieta et al.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 05, 2022

Airborne Transmission of SARS-CoV-2 Delta Variant within Tightly Monitored Isolation Facility, New Zealand (Aotearoa).

Airborne Transmission of SARS-CoV-2 Delta Variant within Tightly Monitored Isolation Facility, New Zealand (Aotearoa).

Journal: Emerging infectious diseases

Published: December 29, 2021

Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand.

Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: August 05, 2021

Creating symptom-based criteria for diagnostic testing: a case study based on a multivariate analysis of data collected during the first wave of the COVID-19 pandemic in New Zealand.

Creating symptom-based criteria for diagnostic testing: a case study based on a multivariate analysis of data collected during the first wave of the COVID-19 pandemic in New Zealand.

Journal: BMC infectious diseases

Published: June 02, 2021

Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing.

Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing.

Journal: Emerging infectious diseases

Published: January 05, 2021

Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand.

Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand.

Journal: medRxiv : the preprint server for health sciences

Published: November 17, 2020

Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand.

Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand.

Journal: Nature communications

Published: November 02, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026